Psychosis Clinical Trials

A research study is enrolling for those suffering from Mild to Cognitive Impairment due to Alzheimer's Disease.  

Participate in a clinical trial exploring memory loss at ActivMed Practices and Research, Inc. in Methuen, MA.  

People with Alzheimer ’s disease are asked to participate in a research study being conducted by New York University School of Medicine.  

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of an investigational medication in adults with mild to moderate Alzheimer's Disease (AD).  

The TauRX study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild  Alzheimer's disease, compared to a placebo. The study drug is a tablet which is taken by mouth twice per day. The study will last approximately 8 months.  

The Trailblazer study is investigating the safety, tolerability, and efficacy of an investigational drug on symptoms of cognitive and functional decline in individuals with early Alzheimer's disease. The study drug is an infusion that will be administered once per week for 75 weeks. The study will last approximately two and ...

Are you starting to experience memory problems? Are slight memory problems affecting your ability to do regular activities? Has anyone noticed a change in your memory? Do you have a family history of Alzheimer’s Disease? If so, you may be experiencing the first signs of memory loss. You may qualify ...

A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression  

The purpose of this study is to understand whether the drug, pimavanserin, improves symptoms of hallucinations and/or delusions experienced in people with dementia.

Clinical research study of an investigational drug that may help slow or stop memory loss in people with early stages of Alzheimer's disease.